Legal Requirement
A. Legal requirement:
Regulation 29A of the Medicines for Human Use (Clinical Trials) Regulations 2004 [Statutory Instrument 2004/1031], as amended by Statutory Instrument 2006/1928, contains a requirement for the notification of “serious breaches” of GCP or the trial protocol:
“29A. (1) The sponsor of a clinical trial shall notify the licensing authority in writing of any serious breach of –
(a) the conditions and principles of GCP in connection with that trial; or
(b) the protocol relating to that trial, as amended from time to time in accordance with regulations 22 to 25, within 7 days of becoming aware of that breach.
(2) For the purposes of this regulation, a “serious breach” is a breach which is likely to effect to a significant degree –
(a) the safety or physical or mental integrity of the subjects of the trial; or
(b) the scientific value of the trial”.
Clinical Research News
Upcoming Clinical Trials
-
NCT03824847Not yet recruitingConditions: Influenza, Human
-
NCT03823833Not yet recruitingConditions: Endometriosis, Dermoid Cyst, Mucinous Cyst
-
NCT03823820Not yet recruitingConditions: Hydration
-
NCT03822585Not yet recruitingConditions: Beta-Thalassemia
-
NCT03822338Not yet recruitingConditions: Ischemia Reperfusion Injury
-
NCT03821389Not yet recruitingConditions: Respiratory Insufficiency
-
NCT03821220Not yet recruitingConditions: Diabetes Mellitus
-
NCT03821181Not yet recruitingConditions: Moyamoya Disease, TIA, Children, Stroke
-
NCT03820999Not yet recruitingConditions: Lyme Neuroborreliosis
-
NCT03820921Not yet recruitingConditions: Pancreatic Cancer
Recent CRA jobs
-
Data Management Lead I (FSP), multiple EMEA locations
-
FSP Clinical Research Associate / FSP 臨床開発モニター(東京・大阪・神戸)
-
Biotech Partnership Enablement, Associate Director
-
Vendor Quality Specialist
-
Advisor - Communications & Engagement
-
Animal Program Support Specialist 1
-
Technician Toxicology
-
Cagewash Technician ($500 sign on bonus)
-
Sr. Manager Biomarkers
-
Senior Manager - Bioanalytical Chemistry